Health for Life Capital is the first and unique microbiome focused investment vehicle. Now it has been announced that Novartis and other investors have also become strategic investors, pushing the funding pool up by an additional €60M.
Seventure (listed in our top 15 VCs in Europe piece), created the first worldwide €100M fund committed to the Microbiome field (read our January review of the field here). Under the leadership of Seventure’s CEO Isabelle de Cremoux, it has surpassed the initial set objectives and supports the successful visionary strategy of Seventure Partners in the microbiome field.
We met Isabelle at the Bio Europe Conference in March, who told Labiotech that they were actively seeking the next ‘big thing’ in Microbiomics,